Logo image of ECC

EAGLE POINT CREDIT CO INC (ECC) Stock Price, Quote, News and Overview

NYSE:ECC - New York Stock Exchange, Inc. - US2698081013 - Currency: USD

7.53  0 (0%)

After market: 7.52 -0.01 (-0.13%)

Fundamental Rating

3

ECC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. ECC may be in some trouble as it scores bad on both profitability and health. ECC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ECC had positive earnings in the past year.
ECC had a negative operating cash flow in the past year.
ECC had positive earnings in 4 of the past 5 years.
In the past 5 years ECC reported 4 times negative operating cash flow.
ECC Yearly Net Income VS EBIT VS OCF VS FCFECC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M -400M

1.2 Ratios

Industry RankSector Rank
ROA 5.33%
ROE 7.56%
ROIC 5.84%
ROA(3y)1.32%
ROA(5y)6.59%
ROE(3y)1.24%
ROE(5y)9.12%
ROIC(3y)6.93%
ROIC(5y)6.24%
ECC Yearly ROA, ROE, ROICECC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

In the last couple of years the Profit Margin of ECC has declined.
ECC's Operating Margin has improved in the last couple of years.
In the last couple of years the Gross Margin of ECC has grown nicely.
Industry RankSector Rank
OM 59.47%
PM (TTM) 44.67%
GM 62.95%
OM growth 3Y5.72%
OM growth 5Y2.96%
PM growth 3Y-33.04%
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y2.17%
ECC Yearly Profit, Operating, Gross MarginsECC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

1

2. Health

2.1 Basic Checks

ECC has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ECC has more shares outstanding
Compared to 1 year ago, ECC has a worse debt to assets ratio.
ECC Yearly Shares OutstandingECC Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ECC Yearly Total Debt VS Total AssetsECC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

ECC has an Altman-Z score of 1.31. This is a bad value and indicates that ECC is not financially healthy and even has some risk of bankruptcy.
ECC has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 1.31
ROIC/WACCN/A
WACCN/A
ECC Yearly LT Debt VS Equity VS FCFECC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

ECC has a Current Ratio of 1.59. This is a normal value and indicates that ECC is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.59 indicates that ECC should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.59
ECC Yearly Current Assets VS Current LiabilitesECC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

5

3. Growth

3.1 Past

ECC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.97%.
Measured over the past years, ECC shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.24% on average per year.
The Revenue has grown by 29.26% in the past year. This is a very strong growth!
The Revenue has been growing by 22.03% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-13.97%
EPS 3Y-5.35%
EPS 5Y-2.24%
EPS Q2Q%-27.27%
Revenue 1Y (TTM)29.26%
Revenue growth 3Y26.64%
Revenue growth 5Y22.03%
Sales Q2Q%25.75%

3.2 Future

Based on estimates for the next years, ECC will show a decrease in Earnings Per Share. The EPS will decrease by -9.93% on average per year.
Based on estimates for the next years, ECC will show a quite strong growth in Revenue. The Revenue will grow by 16.87% on average per year.
EPS Next Y-10.15%
EPS Next 2Y-9.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year24.6%
Revenue Next 2Y16.87%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ECC Yearly Revenue VS EstimatesECC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ECC Yearly EPS VS EstimatesECC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.44, the valuation of ECC can be described as very cheap.
The average S&P500 Price/Earnings ratio is at 26.86. ECC is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 7.16, the valuation of ECC can be described as very cheap.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.43, ECC is valued rather cheaply.
Industry RankSector Rank
PE 6.44
Fwd PE 7.16
ECC Price Earnings VS Forward Price EarningsECC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ECC Per share dataECC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

A cheap valuation may be justified as ECC's earnings are expected to decrease with -9.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.93%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

ECC has a Yearly Dividend Yield of 21.19%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.43, ECC pays a better dividend.
Industry RankSector Rank
Dividend Yield 21.19%

5.2 History

ECC has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of ECC decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
ECC Yearly Dividends per shareECC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

ECC pays out 204.02% of its income as dividend. This is not a sustainable payout ratio.
DP204.02%
EPS Next 2Y-9.93%
EPS Next 3YN/A
ECC Yearly Income VS Free CF VS DividendECC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M -400M
ECC Dividend Payout.ECC Dividend Payout, showing the Payout Ratio.ECC Dividend Payout.PayoutRetained Earnings

EAGLE POINT CREDIT CO INC

NYSE:ECC (6/26/2025, 8:04:00 PM)

After market: 7.52 -0.01 (-0.13%)

7.53

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-19 2025-05-19/bmo
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners8.98%
Inst Owner Change19.08%
Ins Owners0.18%
Ins Owner Change0.35%
Market Cap904.96M
Analysts77.78
Price Target8.35 (10.89%)
Short Float %3.02%
Short Ratio2.37
Dividend
Industry RankSector Rank
Dividend Yield 21.19%
Yearly Dividend1.74
Dividend Growth(5Y)N/A
DP204.02%
Div Incr Years1
Div Non Decr Years1
Ex-Date08-11 2025-08-11 (0.14)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.74%
Min EPS beat(2)-13.9%
Max EPS beat(2)-13.58%
EPS beat(4)1
Avg EPS beat(4)-9.52%
Min EPS beat(4)-13.9%
Max EPS beat(4)1.47%
EPS beat(8)2
Avg EPS beat(8)-11.71%
EPS beat(12)3
Avg EPS beat(12)-9.68%
EPS beat(16)5
Avg EPS beat(16)-6.4%
Revenue beat(2)1
Avg Revenue beat(2)1.21%
Min Revenue beat(2)-1.41%
Max Revenue beat(2)3.83%
Revenue beat(4)1
Avg Revenue beat(4)-1.69%
Min Revenue beat(4)-6.65%
Max Revenue beat(4)3.83%
Revenue beat(8)3
Avg Revenue beat(8)-2.27%
Revenue beat(12)6
Avg Revenue beat(12)-1.25%
Revenue beat(16)10
Avg Revenue beat(16)0.5%
PT rev (1m)-12.08%
PT rev (3m)-14.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.77%
EPS NY rev (1m)-2.36%
EPS NY rev (3m)-3.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.01%
Revenue NY rev (1m)1.56%
Revenue NY rev (3m)2.79%
Valuation
Industry RankSector Rank
PE 6.44
Fwd PE 7.16
P/S 5.03
P/FCF N/A
P/OCF N/A
P/B 0.85
P/tB 0.85
EV/EBITDA N/A
EPS(TTM)1.17
EY15.54%
EPS(NY)1.05
Fwd EY13.96%
FCF(TTM)-3.57
FCFYN/A
OCF(TTM)-3.57
OCFYN/A
SpS1.5
BVpS8.84
TBVpS8.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.33%
ROE 7.56%
ROCE 7.39%
ROIC 5.84%
ROICexc 6.02%
ROICexgc 6.03%
OM 59.47%
PM (TTM) 44.67%
GM 62.95%
FCFM N/A
ROA(3y)1.32%
ROA(5y)6.59%
ROE(3y)1.24%
ROE(5y)9.12%
ROIC(3y)6.93%
ROIC(5y)6.24%
ROICexc(3y)7.33%
ROICexc(5y)6.51%
ROICexgc(3y)7.34%
ROICexgc(5y)6.51%
ROCE(3y)8.78%
ROCE(5y)7.89%
ROICexcg growth 3Y7.57%
ROICexcg growth 5Y-0.43%
ROICexc growth 3Y7.47%
ROICexc growth 5Y-0.49%
OM growth 3Y5.72%
OM growth 5Y2.96%
PM growth 3Y-33.04%
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y2.17%
F-Score1
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 5.98
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.59
Quick Ratio 1.59
Altman-Z 1.31
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.97%
EPS 3Y-5.35%
EPS 5Y-2.24%
EPS Q2Q%-27.27%
EPS Next Y-10.15%
EPS Next 2Y-9.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)29.26%
Revenue growth 3Y26.64%
Revenue growth 5Y22.03%
Sales Q2Q%25.75%
Revenue Next Year24.6%
Revenue Next 2Y16.87%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.3%
EBIT growth 3Y33.88%
EBIT growth 5Y25.64%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-425.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-425.93%
OCF growth 3YN/A
OCF growth 5YN/A